Zhou Yuqin, Tian Hao, Zhang Guozhi, Hu Baoquan, Wang Yingjiao, Yan Wenting, Wu Xiujuan, Zhang Kongyong, Deng Jun, Liang Yan, Qi Xiaowei, Ren Lin, Zhang Yi
Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis and Treatment of Breast Cancer, Chongqing, China.
Int J Surg. 2025 Jun 1;111(6):3710-3721. doi: 10.1097/JS9.0000000000002418. Epub 2025 Apr 25.
Minimal-access surgery has been widely used in differentiated thyroid cancer (DTC) management and its therapeutic effectiveness is well-proven. However, little is known about how minimal-access thyroidectomy affects patient-reported outcomes (PRO).
In this real-world cross-sectional study, 6221 patients with DTC who underwent minimal-access or conventional open thyroidectomy were included and required to fill out PRO questionnaires, including the Thyroid Cancer-Specific Quality of Life, the European Organisation for Research and Treatment of Cancer's Core Quality of Life Questionnaire, and Fear of Progression Questionnaire-Short Form. Of the 3586 patients who completed the questionnaires entirely, 915 and 2671 belonged to the minimal-access and open groups, respectively. To reduce bias and balance confounding factors, propensity score matching was performed, after which 1818 patients were equally divided between the two groups.
Compared with the open group, the minimal-access group reported better PRO in terms of the THYCA-QOL summary score ( P < 0.001), neuromuscular ( P = 0.038), voice ( P < 0.001), concentration ( P = 0.044), sympathetic ( P = 0.002), throat/mouth ( P < 0.001), and scar ( P < 0.001), feeling chilly ( P < 0.001), and tingling hands/feet ( P = 0.002). Subgroup analysis demonstrated that minimal-access thyroidectomy can be optimal for most patients from the PRO perspective. Moreover, longitudinal PRO comparisons indicated that at ≤6 months postoperatively, the open group experienced more problems in neuromuscular, voice, sympathetic, throat/mouth, scar, feeling chilly, tingling hands/feet, headache, and lower global health status scores (all P < 0.05). However, except for voice, scar and tingling hands/feet, nearly all the differences disappeared after 7 months postoperatively. Intergroup comparisons suggested that the minimal-access group required less time to recover to a stable state.
The minimal-access group exhibited significantly superior postoperative PRO compared to the open group. Furthermore, the PRO trajectories of the two groups differed, with the minimal-access group demonstrating a considerably shorter recovery time. If better PRO is desired, minimal-access thyroidectomy may be preferred.
微创外科手术已广泛应用于分化型甲状腺癌(DTC)的治疗,其治疗效果已得到充分证实。然而,关于微创甲状腺切除术如何影响患者报告结局(PRO),人们了解甚少。
在这项真实世界横断面研究中,纳入了6221例行微创或传统开放性甲状腺切除术的DTC患者,并要求他们填写PRO问卷,包括《甲状腺癌特异性生活质量问卷》《欧洲癌症研究与治疗组织核心生活质量问卷》以及《恐惧疾病进展简明问卷》。在3586例完整填写问卷的患者中,915例和2671例分别属于微创组和开放组。为减少偏倚并平衡混杂因素,进行了倾向得分匹配,之后两组各有1818例患者。
与开放组相比,微创组在甲状腺癌特异性生活质量(THYCA-QOL)总分(P < 0.001)、神经肌肉(P = 0.038)、声音(P < 0.001)、注意力(P = 0.044)、交感神经(P = 0.002)、咽喉/口腔(P < 0.001)、瘢痕(P < 0.001)、畏寒(P < 0.001)以及手足麻木(P = 0.002)方面报告的PRO更好。亚组分析表明,从PRO角度来看,微创甲状腺切除术对大多数患者可能是最佳选择。此外,PRO的纵向比较表明,术后≤6个月时,开放组在神经肌肉、声音、交感神经、咽喉/口腔、瘢痕、畏寒、手足麻木、头痛以及整体健康状况评分方面存在更多问题(均P < 0.05)。然而,除声音、瘢痕和手足麻木外,术后7个月后几乎所有差异均消失。组间比较表明,微创组恢复到稳定状态所需时间更短。
与开放组相比,微创组术后PRO明显更优。此外,两组的PRO轨迹不同,微创组恢复时间明显更短。如果希望获得更好的PRO,微创甲状腺切除术可能更受青睐。